Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 228Leukemia, Lymphocytic, Chronic, B-Cell 211Leukemia 201Myelodysplastic Syndromes 184Precursor Cell Lymphoblastic Leukemia-Lymphoma 172Lymphoma 147Lymphoma, Non-Hodgkin 141Multiple Myeloma 130Hodgkin Disease 121Lymphoma, Follicular 110Lymphoma, Mantle-Cell 107Lymphoma, Large B-Cell, Diffuse 95Lymphoma, B-Cell, Marginal Zone 88Myeloproliferative Disorders 86Congenital Abnormalities 84Burkitt Lymphoma 84Leukemia, Myelomonocytic, Chronic 77Leukemia, Myelogenous, Chronic, BCR-ABL Positive 75Leukemia, Myeloid, Chronic-Phase 74Leukemia, Myeloid, Accelerated Phase 72Recurrence 62Melanoma 62Lymphoma, Large-Cell, Immunoblastic 60Anemia, Refractory, with Excess of Blasts 60Primary Myelofibrosis 55Neoplasms, Plasma Cell 55Waldenstrom Macroglobulinemia 54Blast Crisis 54Hematologic Neoplasms 44Lymphoma, T-Cell, Cutaneous 42

Interventions

Colposcopy 15Imiquimod 13Conization 11Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Cryotherapy 7Papillomavirus Vaccines 6Biopsy 6Acetic Acid 6human papillomavirus vaccine, L1 type 16, 18 5Vaginal Smears 5Watchful Waiting 4Human Papillomavirus DNA Tests 4Vaccines 3Blood Specimen Collection 3VGX-3100 2Transurethral Resection of Prostate 2Spectrometry, Fluorescence 2Restraint, Physical 2Proflavine 2Polymerase Chain Reaction 2Mass Screening 2Indomethacin 2Human Papillomavirus Recombinant Vaccine nonavalent 2High-Throughput Screening Assays 2GX-188 vaccine 2Fluorouracil 2Flow Cytometry 2Cyclophosphamide 2Curcumin 2Celecoxib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uterine Cervical Dysplasia × fludarabine phosphate × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡